SEC Filings | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
May 9, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0000320017-23-000028.pdf 0000320017-23-000028.rtf 0000320017-23-000028.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 1, 2023	8-K	Report of unscheduled material events or corporate event	0000320017-23-000021.pdf 0000320017-23-000021.rtf 0000320017-23-000021.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 1, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0000320017-23-000022.pdf 0000320017-23-000022.rtf 0000320017-23-000022.xls View HTML
May 1, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0000320017-23-000023.pdf 0000320017-23-000023.rtf 0000320017-23-000023.xls View HTML
Mar 30, 2023	8-K	Report of unscheduled material events or corporate event	0000320017-23-000010.pdf 0000320017-23-000010.rtf 0000320017-23-000010.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Mar 30, 2023	10-K	Annual report which provides a comprehensive overview of the company for the past year	0000320017-23-000011.pdf 0000320017-23-000011.rtf 0000320017-23-000011.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Feb 6, 2023	8-K	Report of unscheduled material events or corporate event	0000320017-23-000003.pdf 0000320017-23-000003.rtf 0000320017-23-000003.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Jan 17, 2023	4	Statement of changes in beneficial ownership of securities	0001334549-23-000006.pdf 0001334549-23-000006.rtf 0001334549-23-000006.xls View HTML
Jan 12, 2023	4	Statement of changes in beneficial ownership of securities	0001334549-23-000004.pdf 0001334549-23-000004.rtf 0001334549-23-000004.xls View HTML
Jan 11, 2023	4	Statement of changes in beneficial ownership of securities	0001879231-23-000002.pdf 0001879231-23-000002.rtf 0001879231-23-000002.xls View HTML

Data provided by Kaleidoscope.